Daniel Stadlbauer
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- Epidemiology top 2%
- Influenza Virus Research Studies
Papers in
- Epidemiology 34
- Influenza Virus Research Studies 33
- Cytomegalovirus and herpesvirus research 1
-
- SARS-CoV-2 and COVID-19 Research 17
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 detection and testing 3
- Co-authors
- Florian Krammer (28 shared papers)Fatima Amanat (11 shared papers)Meagan McMahon (8 shared papers)Shirin Strohmeier (10 shared papers)Viviana R. Simon (5 shared papers)Philip S. Meade (4 shared papers)Raffael Nachbagauer (15 shared papers)Kaijun Jiang (4 shared papers)
- Journals
- Nature Communications (10 papers)npj Vaccines (5 papers)Nature Medicine (4 papers)The Journal of Infectious Diseases (3 papers)Emerging Microbes & Infections (2 papers)
- Partner nations
- United StatesAustriaNicaragua
In The Last Decade
Daniel Stadlbauer
58 papers receiving 6.4k citations
Daniel Stadlbauer's Hit Papers
Peers
Comparison fields: 5 of 110
- Infectious Diseases 4.3k
- Epidemiology 1.3k
- Modeling and Simulation 174
- Virology 79
- Immunology 216
Countries citing papers authored by Daniel Stadlbauer
This map shows the geographic impact of Daniel Stadlbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Stadlbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Stadlbauer more than expected).
Fields of papers citing papers by Daniel Stadlbauer
This network shows the impact of papers produced by Daniel Stadlbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Stadlbauer. The network helps show where Daniel Stadlbauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Stadlbauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A serological assay to detect SARS-CoV-2 seroconversion in humans Hit paper breakdown → | 2020 | 1408 |
| 2 | Robust neutralizing antibodies to SARS-CoV-2 infection persist for months Hit paper breakdown → | 2020 | 930 |
| 3 | Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine Hit paper breakdown → | 2021 | 552 |
| 4 | 2020 | 522 | |
| 5 | 2020 | 380 | |
| 6 | SARS-CoV-2 spike E484K mutation reduces antibody neutralisation Hit paper breakdown → | 2021 | 294 |
| 7 | A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial Hit paper breakdown → | 2020 | 272 |
| 8 | 2019 | 202 | |
| 9 | 2021 | 166 | |
| 10 | 2019 | 159 | |
| 11 | 2020 | 125 | |
| 12 | 2020 | 99 | |
| 13 | Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis Hit paper breakdown → | 2023 | 94 |
| 14 | SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase Hit paper breakdown → | 2024 | 92 |
| 15 | 2019 | 80 | |
| 16 | Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates Hit paper breakdown → | 2024 | 74 |
| 17 | 2000 | 71 | |
| 18 | 2019 | 69 | |
| 19 | 2021 | 68 | |
| 20 | 2020 | 66 |
About Daniel Stadlbauer
Daniel Stadlbauer is a scholar working on Epidemiology, Infectious Diseases, Neurology, Applied Microbiology and Biotechnology and Virology, having authored 61 papers that have together received 6.5k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (33 papers), SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 detection and testing (3 papers), Long-Term Effects of COVID-19 (3 papers), Poxvirus research and outbreaks (1 paper), Respiratory Support and Mechanisms (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Infectious Diseases (4.3k citations), Epidemiology (1.3k citations), Modeling and Simulation (174 citations), Virology (79 citations) and Immunology (216 citations). Daniel Stadlbauer has collaborated with scholars based in United States, Austria and Nicaragua. Frequent co-authors include Florian Krammer, Fatima Amanat, Meagan McMahon, Shirin Strohmeier, Viviana R. Simon, Philip S. Meade, Raffael Nachbagauer, Kaijun Jiang, Damodara Rao Mendu and Carlos Cordon‐Cardo. Their work appears in journals such as Nature Communications, npj Vaccines, Nature Medicine, The Journal of Infectious Diseases and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.